Li-Fraumeni Syndrome (LFS) is characterized by heterozygous germline mutations in the p53 gene. Accompanied by genomic instability and loss or mutation of the remaining wild type p53 allele, a low frequency of spontaneous immortalization in LFS ®broblasts occurs. It is believed that the loss of p53 wild type function contributes to immortalization of these LFS ®broblasts, but it is not clear if this is sucient. Because stabilization of telomere length is also thought to be a necessary step in immortalization, telomerase activity, expression of the telomerase RNA component (hTR) and telomere length were analysed at various passages during the spontaneous immortalization of LFS skin ®broblasts. One LFS strain which immortalized, MDAH087 (087), had no detectable telomerase activity whereas another LFS strain which immortalized, MDAH041 (041), had detectable telomerase activity. In preimmortal cells from both strains, hTR was not detected by in situ hybridization. Immortal 087 cells remained negative for hTR, while immortal 041 cells demonstrated strong hTR in situ hybridization signals. 087 cells had long and heterogenous telomeres whereas telomeres of 041 cells had short, stable telomere lengths. Tumorigenicity studies in nude mice with ras-transformed 087 and 041 cells resulted in both cell lines giving rise to tumors and retaining telomerase status. Overall these results suggest that strain speci®city may be important in telomerase re-activation and that both abrogation of p53 function and a mechanism to maintain telomeres are necessary for immortalization.
Introduction
Cellular immortalization is thought of as the capacity for normal diploid cells to escape cellular senescence. There appear to be two discrete stages, Mortality stage 1 (M1) and Mortality stage 2 (M2), that need to be overcome for human cells to bypass normal senescence programming before immortalizing (Wright et al., 1989; Wright and Shay, 1992) . Cells may be immortalized through the introduction of viral and cellular oncogenes such as SV40 large T-antigen (Huschtscha and Holliday, 1983; Shay et al., 1993a; Van Der Haegen and Shay, 1993) , adenovirus E1A/E1B (Graham and Smiley, 1977; Ross et al., 1978; Sarnow et al., 1982) , high risk strains of human papillomavirus (Band et al., 1993; Schener et al., 1990; Shay et al., 1991a Shay et al., , 1993b Watanabe et al., 1993; Werness et al., 1990) , mutant p53 (Eliyahu et al., 1984b; Gao et al., 1996; Gollahon and Shay, 1996; Rogan et al., 1995; Slingerland et al., 1993; Wyllie et al., 1993) , various human oncogenes such as c-myc, Hras (Avery et al., 1944; Bischo et al., 1991; Eliyahu et al., 1984a; Gutman and Wasylyk, 1991; Lemoine et al., 1990) , and rarely, spontaneously (Bischo et al., 1990; Rogan et al., 1995; Shay et al., 1995) . Fibroblast cells appear to immortalize less frequently than epithelial cells (Shay et al., 1993a) , suggesting that the frequency of immortalization may be cell lineage speci®c (Gao et al., 1996; Gollahon and Shay, 1996; Hsiao et al., 1997; Huschtscha and Holliday, 1983; Rainey et al., 1994; Shay et al., 1993a; Van Der Haegen and Shay, 1993; Wazer et al., 1995; Wright et al., 1989; Wyllie et al., 1993) . The requirements to overcome the M1/M2 cellular senescence program appear to be more stringently regulated in ®broblasts than in epithelial cells (Bischo et al., 1990 (Bischo et al., , 1991 McCormick and Maher, 1988; Shay et al., 1993a,b; Wright et al., 1989 ) although a molecular explanation for this has not been determined.
Complementation studies of somatic cell hybrids (Pereira-Smith and Smith, 1988) have demonstrated that some immortal6immortal cell fusions may still senesce depending on the cell combinations used and that all mortal6immortal hybrids senesce suggesting that mortality is a dominant trail (Karlsson et al., 1996; Wright et al., 1996) . In addition, several studies of cellular senescence induced by microcell chromosome mediated fusion have been reported (Barrett, 1993; Ohmura et al., 1995; Saski et al., 1994) . One study demonstrated that the speci®c introduction of chromosome 3 but not other chromosomes into an immortal human renal cell carcinoma line expressing telomerase resulted in the downregulation of telomerase activity, progressive loss of telomere length, and eventual inhibition of cell growth (Ohmura et al., 1995) .
The ribonucleoprotein enzyme telomerase has been shown to be active in 85% of primary human tumors tested (Bacchetti and Counter, 1995; Shay and Bacchetti, 1997) and in over 90% of tumor-derived and experimentally immortalized cell lines (Avilion et al., 1996; Bacchetti and Counter, 1995; Shay and Bacchetti, 1997; Shay and Wright, 1996) . The proposed function of telomerase is thought to be in the maintenance of telomeric length in immortal cells. Telomeric repeats (TTAGGG) are lost with each successive cell division since DNA polymerase cannot completely replicate the end of a DNA duplex (Blackburn, 1991 (Blackburn, , 1994 Greider, 1991; Harley and Villaponteau, 1995; Olovnikov, 1973; Watson, 1972) . This`end replication problem' is considered an important biological timing mechanism (clock) that may determine the replicative capacity of all somatic cells which lack or have low levels of telomerase (Harley, 1991) . The upregulation or reactivation of telomerase appears to correlate with unlimited proliferation potential of a cell, and telomere stability (Shay et al., 1991b) .
Telomeres are also important in the maintenance of chromosomal stability (Counter et al., 1992; Murnane et al., 1994) . In cells that bypass the normal cellular senescence pathway (Shay et al., 1991b) , the reactivation of telomerase occurs when the telomeres have reached a critically shortened length (Harley et al., 1990) . Currently, there are no reports of telomerasenegative tumor-derived cell lines with short telomeres (58 kb) (Avilion et al., 1996; Harley et al., 1994; Shay and Bacchetti, 1997) . However, several examples of experimentally immortalized cultured cell lines have been reported that proliferate inde®nitely with long, heterogenous telomere lengths, without the presence of detectable telomerase activity Duncan et al., 1993; Murnane et al., 1994; Wright et al., 1989; Wright and Shay, 1992) .
The present report demonstrates that the ability to re-activate telomerase or to utilize the ALT pathway to immortalization may be strain-speci®c in ®broblasts derived from individuals with LFS. Our results indicate that in LFS 087 (tel7) ®broblasts, immortalization appears to correlate with p53 status but not telomerase reactivation, whereas in the 041 (tel+) LFS ®broblasts, loss of functional p53 and telomerase reactivation appear to occur at approximately the same time. However, spontaneous immortalization of telomerase negative LFS ®broblasts appears to retain telomere lengths greater than a preprogrammed, speci®c critical length. Additionally, this is the ®rst report of human tumor formation in nude mice by a telomerase negative cell line (087), suggesting that telomerase activity is not always requisite for tumorigenesis.
Results

LFS cell growth characteristics
Normal skin ®broblasts from Li-Fraumeni patients heterozygous for a germline p53 mutation only rarely evolve into immortal cell lines. The molecular mechanism of immortalization is not well understood but is a long process often involving many months of cell culture to obtain a rare clone that immortalizes. In culture, LFS ®broblasts enter a growth crisis period at approximately 25 ± 35 population doublings (PD) characterized by the cells only rarely dividing and mostly dying. During this crisis period, the chromosomes in these cells are highly unstable (Bischo et al., 1990) . After a considerable amount of time (6 ± 12 months), a rare cell in the population reinitiates slow growth until approximately 65 PD at which time the growth rate progressively increases (Bischo et al., 1990) .
Telomerase activity and p53 status in 087 and 041 cells Li-Fraumeni ®broblasts from two patients were studied. The 087 ®broblasts contain a p53 allele with a missense point mutation at amino acid 248. The 041 ®broblasts contain a p53 allele with a point deletion at amino acid 184. This generates the translation of 60 amino acids from the resulting frameshift that are not normally in the p53 protein followed by a premature stop codon (Table 1) . In order to determine whether the loss of wild type p53 is sucient for the reactivation of telomerase activity, DNA prepared from LFS ®broblasts was analysed at various passages for p53 mutations by single strand conformational polymorphism (SSCP) and protein extracts for telomerase activity (Figure 1) . In all LFS ®broblasts examined, the remaining wild type p53 allele was lost (041 cells) or replaced with a mutant p53 allele (087 cells) by PD 67 and absent from all subsequent PD (data not shown). Cell protein extracts from these ®broblasts were analysed for the presence of telomerase activity at various PD during their growth in culture and for loss of p53 protein by Western blot. We (PD 19) and postcrisis (PD 54 and 64, respectively) . A¯atoxin B1 (AFB1) clones were obtained from AFB1 induced immortalization of 087 cells. These AFB1 clones were analysed after 100 PD in culture. Negative control (7) Figure 1b ) and gained detectable telomerase activity that was continuously maintained (Figure 1 ). Since 041 ®broblasts prior to PD 54 did not have detectable telomerase and lost p53 protein at approximately the same time as telomerase reactivation (Figure 1a) , the direct loss of the remaining functional wild type p53 allele appears to correlate with reactivation of telomerase activity.
The spontaneous immortalization of the 087 cells was reproduced consistently, (this study and Bischo et al., 1990) , and therefore represented a good strain to study the frequency of telomerase activation in immortalization. In addition, it has been reported (Tsutsui et al., 1995) that enhancement of the immortalization frequency of 087 cells could be obtained by treatment of cells with a¯atoxin B1 (AFB1) and X-ray treatment, (Tsutsui et al., 1997) . The 087 cell lines never developed detectable telomerase activity (Figure 1a ) in eight of eight independent immortalization experiments including three immortalized by AFB1 (Tsutsui et al., 1995) , one immortalized by X-ray irradiation (Tsutsui et al., 1997) and in four spontaneous immortalization events, (present study and Bischo et al., 1990) . From that immortalization study cells were derived from 087+AFB1 and of these, cells capable of inde®nite proliferation were also found to be telomerase negative (Figure 1a) .
At the time of immortalization, DNA extracts from these cells were examined by SSCP and were found to be homozygous for the p53 mutation at codon 248 (data not shown). Mixing cellular extracts from telomerase negative (087) cells with an extract from a telomerase positive cell line (HT1080) did not result in inhibition of telomerase activity (data not shown) indicating that 087 cells did not contain a diusable telomerase inhibitor. These data (summarized in Table  1 ) indicate that the reactivation of telomerase activity during the immortalization of LFS skin ®broblasts may be cell strain-speci®c.
TRF analysis
The telomere lengths in the LFS skin ®broblasts were estimated using TRF (terminal restriction fragment) analysis to determine if reactivation of telomerase activity in 041 cells resulted in telomere length stabilization, as well as to determine the telomere dynamics of the telomerase negative 087 cells (Figure 2 ). In the 041 cells, a progressive loss of telomeric DNA from 9 kb (PD 21) was observed up to the time of detection of telomerase activity (PD 54), followed by stabilization of telomere length at 4 kb (7ras) as well as the ras-induced immortalized cell lines (+ras). The initial precrisis 041 cells exhibit 2 major telomere subpopulations (9 kb and 4 kb). The larger is lost and it is a shorter subpopulation that determines the stabilized telomeric lengths. The 087 cells retain 2 primary subpopulations of distinct telomeric lengths (10 kb and 2.5 kb) (PD 84). In the telomerase negative 087 cells, TRF analysis showed two not very prominent populations of telomere lengths at approximately 10 kb and 2.5 kb. No major¯uctuations were observed in telomere lengths analysed over approximately 100 PD in culture.
The RNA component of telomerase is enhanced in immortal 041 but not 087 cells
In order to determine whether the RNA component of the telomerase correlates with enzyme activity, telomerase RNA expression levels were determined by in situ hybridization for both 041 (tel+) and 087 (tel7) cell precrisis (530 PD) and postcrisis (560 PD). A probe speci®c for the telomerase RNA component was used (Feng et al., 1995) . As expected for both 041 and 087 preimmortal/precrisis cell strains, the telomerase RNA signal was not above background (Figure 3a and c) . Postcrisis/immortal (PD 236), 041 (tel+) exhibited strong telomerase RNA signal ( Figure  3b ) corresponding with detectable telomerase activity which was maintained at the same levels with continuous passage. In contrast, low or no telomerase RNA signal was observed up to PD 166 for 087 cells (Figure 3d ).
Correlation of telomerase activity with p53 levels
Introduction of wild type p53 utilizing an inducible tetrepressor into TR-9 cells (gift of G Stark and A Agarwal) was performed in order to explore the possibility of a direct correlation between p53 and telomerase activity. TR-9 cells are immortal 041 ®broblasts that were transfected with a wild type p53 cDNA driven by a tetracycline repressible promoter (Gossen and Bujard, 1992) . Concurrently, parallel cultures were exposed to serum at both normal growth concentrations (10%) and low concentrations (0.75%). The rationale for low serum levels was to observe the eects of induced quiescence on telomerase activity and compare this to the eects of p53 induction over time. The inhibition of telomerase by p53 expression was evident after 48 h. In contrast, low serum produced comparable eects on telomerase activity after approximately 2 weeks. As seen in Figure 4a , when tetracycline is removed from the media, p53 is strongly induced and cell growth is arrested. Telomerase activity decreased tenfold over a 7 day period (Figure 4b ). These data are consistent with previous observations (Holt et al., 1996b (Holt et al., , 1997 demonstrating that telomerase competent cells exiting the cell cycle results in downregulation of telomerase activity.
Tumorigenicity studies of 041 and 087 cells in nude mice
Another property of immortalized 041 (tel+) and 087 (tel7) ®broblasts is their susceptibility to ras oncogene transformation (Bischo et al., 1991) . In order to determine if over-expression of ras and/or tumorigenic potential in¯uenced telomerase activation, 041 (tel+) and 087 (tel7) cells at PD 54 and 56, respectively, were transfected with pSV2-neo-H-ras (val 12) and control pSV2-neo plasmids. Clonally derived cell lines expressing the H-ras oncogene were obtained and maintained on 200 mg/ml G418 (Bischo et al., 1991) . Four of ®ve H-ras expressing 041 (tel+) clones formed tumors in nude mice with a latency period of 2 ± 3 weeks. Similarly, 5/7 H-ras expressing 087 (tel7) clones formed tumors in nude mice with a latency period of 1 ± 3 weeks without detection of telomerase activity (data not shown) (Bischo et al., 1991) . The nontumorigenic ras-expressing ®broblast 087 clones, have the mutant form of p53 and grow as cell lines without any indication of senescence. After an additional 50 PD in culture, the two 087 (tel7) rasexpressing nontumorigenic cell clones became tumorigenic in nude mice. No telomerase activity was detected in 087 (tel7) ras-expressing lines that became tumorigenic (data not shown). Figure 5 is a TRAP gel showing telomerase activity of representative 087-ras (tel7) clones and 041-ras (tel+) clones. The tumors derived from 041 cells all retained telomerase activity ( Figure 5) . None of the clones (041 or 087) expressing only pSV2-neo (control) formed tumors in nude mice.
Somatic cell hybrids between 041 or 087 and HT1080
Somatic cell hybrids were made between 041 (tel+, p537) X HT1080 (tel+, p53+) as well as 087 (tel7, p537) X HT1080 (tel+, p53+). We wanted to determine if the cell hybrids would continue dividing, undergo cellular senescence, or growth arrest. Somatic cell hybrids were formed between a telomerase positive, hygromycin resistant ®brosarcoma cell line HT1080, expressing wild type p53, and tumorigenic rastransformed 041 (tel+) and 087 (tel7) ®broblasts containing the gene for neomycin (G418) resistance. Hybrid clones resistant to both hygromycin and G418 readily formed from crosses between HT1080 (tel+, p53+) cells and tumorigenic ras-transformed 087 (tel7, p537) cells. However, there were very few clones obtained between HT1080 (tel+, p53+) and tumorigenic ras-transformed 041 (tel+, p537) cells (Table 2) . The three HT1080/041 ras cell hybrid clones that formed were telomerase positive but senesced rapidly.
All of the hybrid clones tested (10/10) between 087 ras (tel7) and HT1080 (tel+) were telomerase positive and grew inde®nitely. Southern blot analysis with a telomere-speci®c probe was performed using genomic DNA prepared from the HT1080-LFS ®broblast somatic cell hybrids. The hybridization revealed a pattern of DNA fragments that corresponded to the expected telomere lengths from each parent cell line (data not shown).
Discussion
We found that clones from LFS ®broblast cell strains can spontaneously immortalize utilizing either a telomerase dependent or independent mechanism. While telomerase positive immortal LFS cells have stable telomere lengths and high levels of the telomerase RNA (hTR) component, immortal telomerase negative LFS cells lines have long and heterogenous telomere lengths and no observed increase in hTR levels greater than their corresponding preimmortal cell strains (Figure 3c and d ). This suggests, at least in LFS, that some cell strains are committed at an early point to a telomerase positive or telomerase negative immortalization pathway. The TRF analysis in 087 cells revealed two major populations of telomeres. Because the lower band remains unvarying in length throughout culturing, (a) showing that in the presence of wild type p53 there is a 5 ± 10-fold increase in the internal telomerase assay standard (ITAS) signal compared to telomerase activity signal versus 041 cells lacking wild type p53. Also note that the telomerase inhibition in the cells containing induced wild type p53 occurred after only 48 h whereas the cells in low serum conditions show comparable telomerase inhibition after approximately 2 weeks a one possibility is that the longer telomere population is undergoing recombinant events and breakage-fusionsbridge cycles. Alternatively, the shorter telomere population in these cells may serve as the minimum number of TTAGGG repeats required for telomeric function. As the telomere size decreases below this threshold, the cells reenter crisis and a signal may be sent to begin lengthening the telomeres by an as yet unknown mechanism (Lansdorp et al., 1996) . Another possibility for the observed heterogenous telomere length and lack of telomerase activity could involve telomeric binding proteins as previously described (Chong et al., 1995) . For example, telomeric binding proteins may prevent the longer telomeric population from undergoing recombinational events that would maintain that length. As the telomeres shorten, the lack of bound proteins could either allow access of the ends to recombinational events or signal a negative feedback loop that initiates recombination to increase the telomere length.
Induction of wildtype p53 expression in a tetinducible promoter in 041 (tel+) cells resulted in growth arrest with a corresponding inhibition in telomerase activity (Agarwal et al., 1995) . This loss of telomerase activity occurred signi®cantly faster than telomerase inhibition observed under low serum conditions. However, these results do not indicate that there is a direct interaction between wild type p53 and telomerase activity, merely which telomerase activity is downregulated in cells exiting the cell cycle (Holt et al., 1997) . This is consistent with previous observations which show that quiescent cells have reduced telomerase activity (Buchkovich and Greider, 1996; Holt et al., 1996b) . While this is the most likely explanation, our results do not rigorously exclude the possibility that p53 could directly regulate the telomerase holoenzyme.
Tumorigenicity studies in nude mice of ras transformed 041 and 087 cells showed that even with tumor formation, the status of telomerase activity did not change. Our results using LFS ®broblast cells suggests that activation of telomerase activity is not a requirement for immortalization or tumorigenicity since ras-transformed 087 cells formed tumors in nude mice without reactivation of telomerase activity. These results are in agreement with those recently described in a study by (Blasco et al., 1997) in which a telomerase knockout mouse was generated by deleting the gene encoding the telomerase RNA component from the mouse germline. Mice homozygous null for telomerase activity were observed to form tumors at frequencies comparable to normal mice (Blasco et al., 1997) . However, cells transformed with oncogenes could form tumors when reintroduced into mice. The 087 LFS skin ®broblasts do not appear to require a functional telomerase since they maintain their telomeres by an alternative lengthening mechanism. Whether there is a dierence in metastatic capability and telomere status requires further investigation. Another consideration is the p53 status in these cells. One study showed that genomic instability due to p53 germline mutations progresses preneoplastic lesions to cancer in human cells. In this present study of LFS ®broblasts, previously characterized for their genomic instability (Bischo et al., 1990) , positive telomerase activity did not appear to be required for tumor formation. The 087 (tel7) cells formed tumors in nude mice as readily as the 041 (tel+) cells.
Immortal 041 cells that have a p53 frameshift mutation at amino acid 184 resulting in a truncated product and null for the wild type protein, may have the remaining components of the p53 pathway intact, thus leading to complementation and growth suppression in the wild type expressing HT10806041 hybrids. One study reported that some somatic cell hybrids between telomerase positive and telomerase negative cell lines recommenced proliferation after exhibiting cellular senescence. Unlike Bryan et al. (1995) we did not observe reversible cellular senescence in the somatic cell hybrids generated in this study. In contrast, the continued proliferation capability of the HT1080/087 hybrid clones may be due to the presence of the p53 mutant 248 acting as a dominant negative, abrogating the wild type p53 function of the HT1080 cells. However, the poor eciency of generating HT1080/041 hybrids may indicate diering mechanisms of complementation for inactivation of the p53 pathway. Because 041 cells are essentially null for p53, the introduction of the wild type p53 from HT1080 cells may cause a cell cycle arrest that remains separate from telomerase activity. The results from the somatic cell hybrid experiments taken together with the TRF results are consistent with the hypothesis that the wild-type p53 expressed in the HT1080/087 hybrid clones may recognize the long and heterogenous population of telomeres as damaged DNA resulting in a checkpoint growth arrest. The resulting eect would be available telomerase enzyme unable to bind to and replace telomeric TTAGGG repeats and thus telomeres continue to shorten. As the telomeres reach a critical length, p53 may have limited telomere accessibility due to conformational changes, or there may be an unknown mechanism that would allow telomerase to outcompete p53 for the telomeric ends by somehow superseding the p53 binding strategy.
The ALT pathway does not appear to be frequent in primary tumors. It can be observed when viral oncoproteins (e.g. SV40 large T antigen) may predispose certain cells in culture (primarily ®broblasts) to the ALT pathway. Thus, in rare instances, the viral oncogene would integrate into a region(s) that would disrupt the activation of telomerase, such as the RNA component of telomerase or the functional telomerase gene. Our data suggests that such a hypothesis is unlikely since the immortalized cell lines obtained in the present study were spontaneous events. Possibly, it is cell strain speci®c genetic mutations since we have shown in this study and previous studies from patients with p53 germline mutations, the immortalization pathways are consistently and reproducibly dierent in their activation of telomerase activity, telomere structure, and telomerase RNA expression.
In summary, the results from this study suggest that whether cells immortalize via telomerase reactivation or the ALT pathway may be cell strain speci®c. Our results also suggest that the immortalization pathway may be genetically predetermined. Evidence for this includes that 087 (tel7) cells clonally and spontaneously immortalized from eight dierent experiments, never had detectable telomerase activity while the 041 cell immortalization events reactivated telomerase. Telomerase reactivation appears to involve the stabilization of the telomerase lengths whereas the ALT pathway appears to characteristically support long and heterogenous telomeres. Thus, the spontaneous immortalization of LFS cells requires both loss of p53 function and a mechanism to maintain telomeres.
Materials and methods
Cell culture
The cell lines studied (041 and 087) were derived from primary tissues obtained by skin biopsy from patients with Li-Fraumeni Syndrome. Characterization and immortalization of these cells in vitro was previously described (Bischo et al., 1990) . 041 cells contain a frameshift point deletion at codon 184 (GAT ± GAA) which generates the translation of 60 aa from the resulting frameshift that is not normally in the p53 protein, followed by a premature stop codon rendering the cell line null for p53 activity. 087 cells contain a missense point mutation at codon 248 (Arg ± Trp). The growth and maintenance of these LFS ®broblasts was performed as previously described (Bischo et al., 1990) . All cells were grown in modi®ed Eagle's medium with 10% fetal calf serum and antibiotics.
Cell preparation for telomerase analysis
Detection of telomerase activity in cultured cells requires the extension of an oligonucleotide that serves as the substrate for the telomerase enzyme (TS), followed by PCR ampli®cation of the resultant products with the forward (TS) and reverse (CX) primers. Details of the telomeric repeat ampli®cation protocol (TRAP assay) are reported elsewhere (Holt et al., 1996a; Kim et al., 1994; Piatyszek et al., 1995) . TRAP assays were performed using the Oncor TRAPeze TM kit (Gaithersburg, MD). PCR products were electrophoresed on 10% polyacrylamide gels, and the gels were analysed either using PhosphorImaging System from Molecular Dynamics (Sunnyvale, CA) or dried and placed on Kodak Bio Max TM Film (Rochester, NY) overnight. Telomerase activity produces a processive 6 bp RNase sensitive ladder of ampli®cation products. The 36 bp internal standard permits quantitation of relative telomerase activity levels by calculating the ratio of the internal standard to the telomerase ladder.
Telomerase RNA and in situ hybridization
For telomerase RNA analysis, cells were prepared as follows: 50 000 cells were plated per chamber in a 2-chamber slide (Nalge-Nunc, Milwaukee, WI) and allowed to attach overnight. The slides were rinsed in PBS and placed in cold acetone for 20 min. Cells were then prepared for hybridization following established protocols (Jordan, 1990) . Brie¯y, cells were cross-linked in 4% paraformaldehyde (Sigma, St. Louis, MO), permeabilized in 0.05% Triton X-100 (Sigma), and deproteinized in 0.2 N HCl (Sigma), deproteinized a second time with Proteinase K (1 mg/ml) (Gibco), at 378C. The cells were cross-linked again in 4% paraformaldehyde, followed by acetylation with 0.25% acetic anhydride (Sigma) in 0.1 M triethanolamine (Sigma).
Probe preparation
The template used to generate antisense and sense control probes consisted of the human telomerase RNA (hTR) (Geron Corp., Menlo Park, CA) cDNA sequence (560 nucleotides) in a pGEM-5Z plasmid (Feng et al., 1995) . Single-stranded RNA probes labeled with [a 35 S] UTP were synthesized according to manufacturer's instruction (Ambion, Austin, TX). As previously described (Yashima et al., 1997) transcripts were alkaline hydrolyzed to generate an average length of 200 nt for ecient hybridization and puri®ed with G-50 columns (Boerhinger Mannheim, Indianapolis, IN). After ethanol precipitation, the probes were resuspended in 30 ml of 100 mM DTT. Speci®c activity was approximately 3610 7 c.p.m./mg of template DNA.
Hybridization and washing
Hybridization solution consisted of 50% deionized formamide, 0.3 M NaCl, 20 mM Tris-HCl (pH 7.5), 5 mM EDTA, 10 mM NaH 2 PO 4 (pH 8.0), 10% dextran sulfate, 16Denhardt's, 500 mg/ml total yeast RNA, 10 mM DTT and 50 000 c.p.m./ml of the 35 S-labeled RNA probe. Slides were hybridized overnight at 508C. Washes were performed at 508C in 56SSC, 10 mM DTT, then 658C in 50% formamide, 26SSC, 10 mM DTT. The cells were then washed twice in 0.4 M NaCl, 10 mM Tris-HCl (pH 7.5), 5 mM EDTA before treatment with RNase A followed by washes in 26SSC and 0.16SSC. The slides were dehydrated in a graded ethanol series and dipped in Kodak NTB-2 nuclear track emulsion. After drying, the slides were stored in a light-tight box with desiccant at 7808C for 3 ± 4 weeks. Slides were developed in Kodak Dektol developer, rinsed with water, ®xed, rinsed again, counterstained with Gill's Hematoxylin (Fisher, Pittsburgh, PA) and coverslipped with Permount (Sigma). Photomicrography was performed on an Olympus BH-2 microscope using Kodak-400 Elite TM ®lm.
Telomere length measurement
DNA from cultured cells was isolated by dialysis and digested with a six enzyme mix consisting of 10 U each HinfI, AluI, CfoI, HaeIII, MspI and RsaI. 10 mg of digested DNA was electrophoresed on 1.0% agarose gels using ®eld inversion gel electrophoresis (FIGE) (Bio-Rad, Hercules, CA) with forward voltage 180 V, reverse voltage 120 V, for 20 h. Gels were denatured in high salt buer (0.5 M NaOH, 1.5 M NaCl) for 15 min, dried under vacuum at 508C for 45 min and equilibrated in neutralization buer (0.5 M TrisHCl, pH 8, 1.5 M NaCl) 2 times for 15 min. The gels were preincubated in hybridization buer (56SSC, 56Den-hardt's solution, 0.5 M sodium pyrophosphate, 10 mM disodium hydrogen phosphate) at 378C for 4 h. Hybridization was done using fresh buer and the radiolabeled telomeric probe (TTAGGG) 4 for 12 h. Hybridized gels were washed 3 times for 7 min each with 0.16SSC at room temperature and analysed using the PhosphorImaging System from Molecular Dynamics. Terminal Restriction Fragment (TRF) lengths were estimated based on electrophoresis of 1 kb and high molecular weight ladders (Gibco).
Western analysis
Cells were harvested at approximately 80% con¯uence and analysed as previously described (Gillespie and Hudspeth, 1991) . Brie¯y, 20 mg of protein extract was run under 10% SDS ± PAGE conditions. Resolved protein was transferred to ECL TM Nitrocellulose membrane (Amersham, Arlington Heights, IL). For p53, monoclonal antibody DO-1 (Oncogene Science, Cambridge, MA) was applied as per manufacturers instructions and detection was performed using Tropix TM chemiluminescent reagents (Bedford, MA). Blots were exposed to Kodak X-ray ®lm (Rochester, NY).
Somatic cell hybrids
Cells for preparation of somatic cell hybrids were harvested by trypsinization from rapidly growing cell cultures. Somatic cell hybrids were formed by mixing 3610 6 cells of each pair HT1080(hygro R ) with 087ras(neo R ) or HT1080(hygro R ) with 041ras(neo R ), centrifuging at 800 r.p.m. for 6 min, and washing once in 10 ml of serum free media, RPMI 1640. The cells were recentrifuged at 800 r.p.m. for 6 min and resuspended in 1 ml of 50% polyethyleneglycol 1500 (Boehringer Mannheim) in RPMI 1640 prewarmed to 378C. The cells were kept for 1 min at 378C in a water bath. After 1 min, 1 ml of medium was added, and after 2 min, 2 ml of medium was added. This mixture was kept for 4 min at 378C, and then 4 ml of medium was added for a ®nal volume of 8 ml. The mixture was then centrifuged at 800 r.p.m. for 6 min and resuspended gently in RPMI 1640. The washed cells were then centrifuged at 800 r.p.m. for 6 min and resuspended in MEM with 10% FBS and plated at 1610 6 cells per 100 mm tissue culture plate. Drug selection was initiated 24 h later in MEM with 10% FBS using both 100 mg/ml of hygromycin and 200 mg/ml G418. Double drug resistant colonies were picked 3 ± 4 weeks later and used for further studies.
Tetracycline inducible response promoter
The TR-9 cells are immortal 041 cells that contain a repressible wt-p53 expression cassette. Cells were generously supplied by Stark and Agarwal. Stock cultures were maintained in 1 mg/ml tetracyline, 600 mg/ml G418 and 50 mg/ml of hygromycin. For experiments, TR-9 cells were seeded at 2610 6 per 100 mm 2 tissue culture plate in the presence of 600 mg/ ml G418 and 50 mg/ml hygromycin. In cultures in which the wild type p53 was to be repressed, tetracycline was added to 1 mg/ml. Cells were harvested at day 2, 4, 7, 9, 11 and 14 for cell counting, p53 expression and telomerase assays. The growth of the cells is almost immediately halted after removal of tetracycline from the medium. For the early times and for culture in which the wild type p53 was expressed, 2 ± 3 plates of cells were harvested, pooled and counted.
